185 related articles for article (PubMed ID: 19602568)
1. Immunological mimicry of PrPC-PrPSc interactions: antibody-induced PrP misfolding.
Li L; Guest W; Huang A; Plotkin SS; Cashman NR
Protein Eng Des Sel; 2009 Aug; 22(8):523-9. PubMed ID: 19602568
[TBL] [Abstract][Full Text] [Related]
2. Prion protein self-peptides modulate prion interactions and conversion.
Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
[TBL] [Abstract][Full Text] [Related]
3. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
4. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
[TBL] [Abstract][Full Text] [Related]
5. Copper binding to the PrP isoforms: a putative marker of their conformation and function.
Shaked Y; Rosenmann H; Hijazi N; Halimi M; Gabizon R
J Virol; 2001 Sep; 75(17):7872-4. PubMed ID: 11483731
[TBL] [Abstract][Full Text] [Related]
6. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
Zou WQ; Cashman NR
J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
[TBL] [Abstract][Full Text] [Related]
7. Sonication induced intermediate in prion protein conversion.
Zukas AA; Bruederle CE; Carter JM
Protein Pept Lett; 2008; 15(2):206-11. PubMed ID: 18289112
[TBL] [Abstract][Full Text] [Related]
8. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
9. Identifying key components of the PrPC-PrPSc replicative interface.
Abalos GC; Cruite JT; Bellon A; Hemmers S; Akagi J; Mastrianni JA; Williamson RA; Solforosi L
J Biol Chem; 2008 Dec; 283(49):34021-8. PubMed ID: 18826953
[TBL] [Abstract][Full Text] [Related]
10. Mapping the antigenicity of copper-treated cellular prion protein with the scrapie isoform.
Wong BS; Li R; Sassoon J; Kang SC; Liu T; Pan T; Greenspan NS; Wisniewski T; Brown DR; Sy MS
Cell Mol Life Sci; 2003 Jun; 60(6):1224-34. PubMed ID: 12861388
[TBL] [Abstract][Full Text] [Related]
11. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
Horiuchi M; Caughey B
EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
[TBL] [Abstract][Full Text] [Related]
12. Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc.
Khalili-Shirazi A; Kaisar M; Mallinson G; Jones S; Bhelt D; Fraser C; Clarke AR; Hawke SH; Jackson GS; Collinge J
Biochim Biophys Acta; 2007 Nov; 1774(11):1438-50. PubMed ID: 17936697
[TBL] [Abstract][Full Text] [Related]
13. The use of monoclonal antibody epitopes for tagging PrP in conversion experiments.
Vorberg I; Pfaff E; Groschup MH
Arch Virol Suppl; 2000; (16):285-90. PubMed ID: 11214932
[TBL] [Abstract][Full Text] [Related]
14. Different antigenicities of the N-terminal region of cellular and scrapie prion proteins.
Ushiki-Kaku Y; Iwamaru Y; Masujin K; Imamura M; Itohara S; Ogawa-Goto K; Hattori S; Yokoyama T
Microbiol Immunol; 2013 Nov; 57(11):792-6. PubMed ID: 24117858
[TBL] [Abstract][Full Text] [Related]
15. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.
Kim CL; Umetani A; Matsui T; Ishiguro N; Shinagawa M; Horiuchi M
Virology; 2004 Mar; 320(1):40-51. PubMed ID: 15003861
[TBL] [Abstract][Full Text] [Related]
16. Prion Protein-Antibody Complexes Characterized by Chromatography-Coupled Small-Angle X-Ray Scattering.
Carter L; Kim SJ; Schneidman-Duhovny D; Stöhr J; Poncet-Montange G; Weiss TM; Tsuruta H; Prusiner SB; Sali A
Biophys J; 2015 Aug; 109(4):793-805. PubMed ID: 26287631
[TBL] [Abstract][Full Text] [Related]
17. Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibition.
Taguchi Y; Schätzl HM
Prion; 2013; 7(6):452-6. PubMed ID: 24401595
[TBL] [Abstract][Full Text] [Related]
18. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
[TBL] [Abstract][Full Text] [Related]
19. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
[TBL] [Abstract][Full Text] [Related]
20. Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseases.
Madampage CA; Määttänen P; Marciniuk K; Brownlie R; Andrievskaia O; Potter A; Cashman NR; Lee JS; Napper S
Prion; 2013; 7(4):301-11. PubMed ID: 23787697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]